Ahuja Nita 4
4 · ABBOTT LABORATORIES · Filed Apr 28, 2026
Research Summary
AI-generated summary of this filing
Abbott (ABT) Director Nita Ahuja Receives RSU Award — 2,286 Shares
What Happened
- Nita Ahuja, a director of Abbott Laboratories, received a grant of 2,286 restricted stock units (RSUs) on 2026-04-24. The award is reported at $0.00 acquisition price (typical for RSU grants); no cash was paid by the insider. The RSUs will be settled one-for-one in Abbott common shares upon specified events (see footnote).
Key Details
- Transaction date: 2026-04-24; reported on Form 4 filed 2026-04-28.
- Transaction type/code: Award/Grant (A) — 2,286 RSUs @ $0.00.
- Shares owned after transaction: Not specified in the provided filing.
- Footnote: RSUs were granted under the Abbott Laboratories 2026 Incentive Stock Program and will be paid in common shares on the earlier of the director’s separation from service, death, or a change in control.
- Timeliness: Filing was submitted 4/28 for a 4/24 grant, within the standard two-business-day reporting window.
Context
- RSUs are a form of equity compensation that do not convert into actual shares until settlement conditions are met; they are not an immediate purchase or sale. Grants to non-employee directors are common as part of long-term compensation and do not by themselves indicate a near-term buying or selling signal.
Insider Transaction Report
Form 4
Ahuja Nita
Director
Transactions
- Award
Common shares without par value
[F1]2026-04-24+2,286→ 2,286 total
Footnotes (1)
- [F1]Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
Signature
/s/ Nita Ahuja by Jessica H. Paik, Attorney-in-Fact|2026-04-28